Plateletpheresis
Top View
- The Clinical Use of Blood Handbook
- Cell Salvage and Alternative Methods of Minimising Perioperative Allogeneic Blood Transfusion ISSN 1366-5278 Feedback Your Views About This Report
- Management of Citrate Toxicity in Pediatric Patients
- Significant Reduction in Hematological Values After Plateletpharesis: Clinical Implication to the Donor
- Trapping of Platelets in Leukocyte Reduction Chamber Leads
- Citrate Anticoagulant and Apheresis Perspective of Plasma Protein Therapeutics Industry November 29, 2012
- Effect of Donor Variables on Platelet Yield Among Donor
- Donor Apheresis Products
- Regular Review
- Recovery of White Blood Cells and Platelets from Leukoreduction
- Am I Eligible to Donate Blood?
- A Practical Guide to Granulocyte Transfusion Therapy
- Immuno-Magnetic T Cell and Alloreactive T Cell
- Donor Blood-Count Changes During and After Plateletpheresis
- Thrombocytosis and Therapeutic Plateletpheresis Shan Yuan, MD Last Updated August 15, 2011
- Hematological Cellular Alterations in Plateletpheresis Donors
- Guidance for Industry and FDA Review Staff: Collection of Platelets by Automated Methods” Dated September 2005
- Differentiation of Megakaryocytes/Platelets and Neurons from Human Endometrial Stromal Progenitor Cells